Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017 (2017), Article ID 1295087, 10 pages
https://doi.org/10.1155/2017/1295087
Research Article

Proliferative and Invasive Effects of Progesterone-Induced Blocking Factor in Human Glioblastoma Cells

1Unidad de Investigación en Reproducción Humana, Instituto Nacional de Perinatología-Facultad de Química, Universidad Nacional Autónoma de México (UNAM), Ciudad Universitaria, Coyoacán, 04510 Ciudad de México, Mexico
2Facultad de Química, Departamento de Biología, UNAM, Ciudad Universitaria, Coyoacán, 04510 Ciudad de México, Mexico

Correspondence should be addressed to Ignacio Camacho-Arroyo; moc.liamg@oyorraohcamac

Received 8 August 2016; Revised 24 November 2016; Accepted 15 December 2016; Published 12 January 2017

Academic Editor: Jens Schittenhelm

Copyright © 2017 Araceli Gutiérrez-Rodríguez et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Schumacher, R. Guennoun, F. Robert et al., “Local synthesis and dual actions of progesterone in the nervous system: neuroprotection and myelination,” Growth Hormone and IGF Research, vol. 14, pp. S18–S33, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Rodriguez-Dorantes and I. Camacho-Arroyo, “Transcriptional activity regulated by progesterone receptor isoforms,” Molecular Endocrinology, vol. 2006, no. 2, pp. 25–38, 2006. View at Google Scholar
  3. E. Cabrera-Muñoz, A. González-Arenas, M. Saqui-Salces et al., “Regulation of progesterone receptor isoforms content in human astrocytoma cell lines,” Journal of Steroid Biochemistry and Molecular Biology, vol. 113, no. 1-2, pp. 80–84, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. A. G. Piña-Medina, V. Hansberg-Pastor, A. González-Arenas, M. Cerbón, and I. Camacho-Arroyo, “Progesterone promotes cell migration, invasion and cofilin activation in human astrocytoma cells,” Steroids, vol. 105, pp. 19–25, 2016. View at Publisher · View at Google Scholar · View at Scopus
  5. L. Germán-Castelán, J. Manjarrez-Marmolejo, A. González-Arenas, M. G. González-Morán, and I. Camacho-Arroyo, “Progesterone induces the growth and infiltration of human astrocytoma cells implanted in the cerebral cortex of the rat,” BioMed Research International, vol. 2014, Article ID 393174, 8 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  6. G. González-Agüero, A. A. Gutiérrez, D. González-Espinosa et al., “Progesterone effects on cell growth of U373 and D54 human astrocytoma cell lines,” Endocrine, vol. 32, no. 2, pp. 129–135, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Szekeres-Bartho, B. Autran, P. Debre, G. Andreu, L. Denver, and G. Chaouat, “Immunoregulatory effects of a suppressor factor from healthy pregnant women's lymphocytes after progesterone induction,” Cellular Immunology, vol. 122, no. 2, pp. 281–294, 1989. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Druckmann and M.-A. Druckmann, “Progesterone and the immunology of pregnancy,” Journal of Steroid Biochemistry and Molecular Biology, vol. 97, no. 5, pp. 389–396, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. M. Lachmann, D. Gelbmann, E. Kálmán et al., “PIBF (progesterone induced blocking factor) is overexpressed in highly proliferating cells and associated with the centrosome,” International Journal of Cancer, vol. 112, no. 1, pp. 51–60, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. A. González-Arenas, P. Valadez-Cosmes, C. Jiménez-Arellano, M. López-Sánchez, and I. Camacho-Arroyo, “Progesterone-induced blocking factor is hormonally regulated in human astrocytoma cells, and increases their growth through the IL-4R/JAK1/STAT6 pathway,” Journal of Steroid Biochemistry and Molecular Biology, vol. 144, pp. 463–470, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Halasz, B. Polgar, G. Berta, L. Czimbalek, and J. Szekeres-Bartho, “Progesterone-induced blocking factor differentially regulates trophoblast and tumor invasion by altering matrix metalloproteinase activity,” Cellular and Molecular Life Sciences, vol. 70, no. 23, pp. 4617–4630, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. N. Kozma, M. Halasz, B. Polgar et al., “Progesterone-induced blocking factor activates STAT6 via binding to a novel IL-4 receptor,” The Journal of Immunology, vol. 176, no. 2, pp. 819–826, 2006. View at Publisher · View at Google Scholar · View at Scopus
  13. C. de la Haba, J. R. Palacio, T. Palkovics, J. Szekeres-Barthó, A. Morros, and P. Martínez, “Oxidative stress effect on progesterone-induced blocking factor (PIBF) binding to PIBF-receptor in lymphocytes,” Biochimica et Biophysica Acta (BBA)—Biomembranes, vol. 1838, no. 1, pp. 148–157, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Szekeres-Bartho and B. Polgar, “PIBF: the double edged sword. Pregnancy and tumor,” American Journal of Reproductive Immunology, vol. 64, no. 2, pp. 77–86, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Szekeres-Bartho, M. Halasz, and T. Palkovics, “Progesterone in pregnancy; receptor-ligand interaction and signaling pathways,” Journal of Reproductive Immunology, vol. 83, no. 1-2, pp. 60–64, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. B. C. Merk, J. L. Owens, M.-B. S. Lopes, C. M. Silva, and I. M. Hussaini, “STAT6 expression in glioblastoma promotes invasive growth,” BMC Cancer, vol. 11, article 184, 2011. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Anderle, A. Hammer, B. Polgár et al., “Human trophoblast cells express the immunomodulator progesterone-induced blocking factor,” Journal of Reproductive Immunology, vol. 79, no. 1, pp. 26–36, 2008. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Kyurkchiev, E. Naydenov, K. Tumangelova-Yuzeir et al., “Cells isolated from human glioblastoma multiforme express progesterone-induced blocking factor (PIBF),” Cellular and Molecular Neurobiology, vol. 34, no. 4, pp. 479–489, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. J. H. Check, M. Sarumi, A. DiAntonio, K. Hunter, G. Simpkins, and M. Duroseau, “Serum levels of the progesterone induced blocking factor do not precipitously rise in women with gynecologic cancer in contrast to women exposed to progesterone,” Clinical and Experimental Obstetrics and Gynecology, vol. 42, no. 5, pp. 563–567, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. J. H. Check, A. Rosenberg, A. DiAntonio, H. Rui, R. Cohen, and G. DiAntonio, “Abstract 1281: serum levels of the immunomodulatory protein, the progesterone induced blocking factor (PIBF) are not higher in women with progesterone (P) receptor (R) positive vs. negative breast cancer,” Cancer Research, vol. 75, supplement 15, pp. 1281–1281, 2015. View at Publisher · View at Google Scholar
  21. J. H. Check, M. P. Dougherty, G. DiAntonio, J. Vaniver, M. Duroseau, and M. D. Srivastava, “Abstract 1282: comparison of serum progesterone levels of the immunomodulatory protein, the progesterone induced blocking factor, in people with BRCA-2 mutations associated with and not associated with a high risk of cancer,” Cancer Research, vol. 75, no. 15, article 1282, 2015. View at Publisher · View at Google Scholar
  22. V. Calvo and M. Beato, “BRCA1 counteracts progesterone action by ubiquitination leading to progesterone receptor degradation and epigenetic silencing of target promoters,” Cancer Research, vol. 71, no. 9, pp. 3422–3431, 2011. View at Publisher · View at Google Scholar · View at Scopus
  23. D. N. Louis, A. Perry, G. Reifenberger et al., “The 2016 world health organization classification of tumors of the central nervous system: a summary,” Acta Neuropathologica, vol. 131, no. 6, pp. 803–820, 2016. View at Publisher · View at Google Scholar
  24. F. B. Furnari, T. Fenton, R. M. Bachoo et al., “Malignant astrocytic glioma: genetics, biology, and paths to treatment,” Genes and Development, vol. 21, no. 21, pp. 2683–2710, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. J. H. Check, C. Wilson, R. Cohen, and M. Sarumi, “Evidence that mifepristone, a progesterone receptor antagonist, can cross the blood brain barrier and provide palliative benefits for glioblastoma multiforme grade IV,” Anticancer Research, vol. 34, no. 5, pp. 2385–2388, 2014. View at Google Scholar · View at Scopus
  26. A. Authier, K. J. Farrand, K. W. R. Broadley et al., “Enhanced immunosuppression by therapy-exposed glioblastoma multiforme tumor cells,” International Journal of Cancer, vol. 136, no. 11, pp. 2566–2578, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. J. H. Check, P. Nazari, J. Goldberg, W. Yuen, and D. Angotti, “A model for potential tumor immunotherapy based on knowledge of immune mechanisms responsible for spontaneous abortion,” Medical Hypotheses, vol. 57, no. 3, pp. 337–343, 2001. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Waziri, “Glioblastoma-derived mechanisms of systemic immunosuppression,” Neurosurgery Clinics of North America, vol. 21, no. 1, pp. 31–42, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. R. Raghupathy, E. Al-Mutawa, M. Al-Azemi, M. Makhseed, F. Azizieh, and J. Szekeres-Bartho, “Progesterone-induced blocking factor (PIBF) modulates cytokine production by lymphocytes from women with recurrent miscarriage or preterm delivery,” Journal of Reproductive Immunology, vol. 80, no. 1-2, pp. 91–99, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. J. H. Check, E. Dix, and L. Sansoucie, “Support for the hypothesis that successful immunotherapy of various cancers can be achieved by inhibiting a progesterone associated immunomodulatory protein,” Medical Hypotheses, vol. 72, no. 1, pp. 87–90, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. L. Cheng, S. Bao, and J. N. Rich, “Potential therapeutic implications of cancer stem cells in glioblastoma,” Biochemical Pharmacology, vol. 80, no. 5, pp. 654–665, 2010. View at Publisher · View at Google Scholar · View at Scopus
  32. M. J. Riemenschneider and G. Reifenberger, “Astrocytic tumors,” Recent Results in Cancer Research, vol. 171, pp. 3–24, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. F. Atif, S. Yousuf, and D. G. Stein, “Anti-tumor effects of progesterone in human glioblastoma multiforme: role of PI3K/Akt/mTOR signaling,” Journal of Steroid Biochemistry and Molecular Biology, vol. 146, pp. 62–73, 2015. View at Publisher · View at Google Scholar · View at Scopus
  34. F. Atif, N. R. Patel, S. Yousuf, and D. G. Stein, “The synergistic effect of combination progesterone and temozolomide on human glioblastoma cells,” PLoS ONE, vol. 10, no. 6, Article ID e0131441, 2015. View at Publisher · View at Google Scholar · View at Scopus
  35. R. A. Cohen, J. H. Check, and M. P. Dougherty, “Evidence that exposure to progesterone alone is a sufficient stimulus to cause a precipitous rise in the immunomodulatory protein the progesterone induced blocking factor (PIBF),” Journal of Assisted Reproduction and Genetics, vol. 33, no. 2, pp. 221–229, 2016. View at Publisher · View at Google Scholar · View at Scopus
  36. A. Bogdan, B. Polgar, and J. Szekeres-Bartho, “Progesterone induced blocking factor isoforms in normal and failed murine pregnancies,” American Journal of Reproductive Immunology, vol. 71, no. 2, pp. 131–136, 2014. View at Publisher · View at Google Scholar · View at Scopus
  37. M. D. Srivastava, A. Thomas, B. I. S. Srivastava, and J. H. Check, “Expression and modulation of progesterone induced blocking factor (PIBF) and innate immune factors in human leukemia cell lines by progesterone and mifepristone,” Leukemia and Lymphoma, vol. 48, no. 8, pp. 1610–1617, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. N. Kozma, M. Halasz, T. Palkovics, and J. Szekeres-Bartho, “The progesterone-induced blocking factor modulates the balance of PKC and intracellular Ca++,” American Journal of Reproductive Immunology, vol. 55, no. 2, pp. 122–129, 2006. View at Publisher · View at Google Scholar · View at Scopus
  39. C. Senft, M. Priester, M. Polacin et al., “Inhibition of the JAK-2/STAT3 signaling pathway impedes the migratory and invasive potential of human glioblastoma cells,” Journal of Neuro-Oncology, vol. 101, no. 3, pp. 393–403, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. M. Priester, E. Copanaki, V. Vafaizadeh et al., “STAT3 silencing inhibits glioma single cell infiltration and tumor growth,” Neuro-Oncology, vol. 15, no. 7, pp. 840–852, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Canellada, I. Alvarez, L. Berod, and T. Gentile, “Estrogen and progesterone regulate the IL-6 signal transduction pathway in antibody secreting cells,” Journal of Steroid Biochemistry and Molecular Biology, vol. 111, no. 3–5, pp. 255–261, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. A. H. Thorne, C. Zanca, and F. Furnari, “Epidermal growth factor receptor targeting and challenges in glioblastoma,” Neuro-Oncology, vol. 18, no. 7, pp. 914–918, 2016. View at Publisher · View at Google Scholar